Directory
Andree Yeramian Hakim

Andree Yeramian Hakim

Degree: PhD

973 70 36 67
andree.yeramian(ELIMINAR)@udl.cat

ResearcherID: http://www.researcherid.com/rid/B-5936-2009

Publications

  • Ruiz-Mitjana, A; Vidal-Sabanés, M; Navaridas, R; Perramon-Güuell, A; Yeramian, A; Nicholson-Sabate, N; Egea, J; Encinas, M; Matias-Guiu, X; Dolcet, X

    Metformin exhibits antineoplastic effects on Pten-deficient endometrial cancer by interfering with TGF-ß and p38/ERK MAPK signalling

    BIOMEDICINE & PHARMACOTHERAPY 168 115817-115817. .

    [doi:10.1016/j.biopha.2023.115817]

  • Navaridas, R; Vidal-Sabanés, M; Ruiz-Mitjana, A; Altés, G; Perramon-Güell, A; Yeramian, A; Egea, J; Encinas, M; Gatius, S; Matias-Guiu, X; Dolcet, X

    In Vivo Intra-Uterine Delivery of TAT-Fused Cre Recombinase and CRISPR/Cas9 Editing System in Mice Unveil Histopathology of Pten/p53-Deficient Endometrial Cancers

    Advanced Science 10 -. .

    [doi:10.1002/advs.202303134]

  • Herrerías-González F; Yeramian A; Baena-Fustegueras JA; Bueno M; Fleitas C; de la Fuente M; Serrano JCE; Granado-Serrano A; Santamaría M; Yeramian N; Zorzano-Martínez M; Mora C; Lecube A

    PKN1 Kinase: A Key Player in Adipocyte Differentiation and Glucose Metabolism.

    Nutrients 15 -. .

    [doi:10.3390/nu15102414]

  • Lopez-Mejia IC; Pijuan J; Navaridas R; Santacana M; Gatius S; Velasco A; Castellà G; Panosa A; Cabiscol E; Pinyol M; Coll L; Bonifaci N; Peña LP; Vidal A; Villanueva A; Gari E; Llobet-Navàs D; Fajas L; Matias-Guiu X; Yeramian A

    Oxidative stress-induced FAK activation contributes to uterine serous carcinoma aggressiveness.

    MOLECULAR ONCOLOGY 17 98-118. .

    [doi:10.1002/1878-0261.13346]

  • Altes, G; Vaquero, M; Cuesta, S; Anerillas, C; Macia, A; Espinet, C; Ribera, J; Bellusci, S; Klein, OD; Yeramian, A; Dolcet, X; Egea, J; Encinas, M

    A dominant negative mutation uncovers cooperative control of caudal Wolffian duct development by Sprouty genes

    Cellular And Molecular Life Sciences 79 514-514. .

    [doi:10.1007/s00018-022-04546-1]

  • Ruiz-Mitjana, A; Navaridas, R; Vidal-Sabanes, M; Perramon-Guell, A; Yeramian, A; Felip, I; Eritja, N; Egea, J; Encinas, M; Matias-Guiu, X; Dolcet, X

    Lack of extracellular matrix switches TGF-ß induced apoptosis of endometrial cells to epithelial to mesenchymal transition.

    SCIENTIFIC REPORTS 12 14821-14821. .

    [doi:10.1038/s41598-022-18976-1]

  • Gatius S; Jove M; Megino-Luque C; Albertí-Valls M; Yeramian A; Bonifaci N; Piñol M; Santacana M; Pradas I; Llobet-Navas D; Pamplona R; Matías-Guiu X; Eritja N

    Metabolomic Analysis Points to Bioactive Lipid Species and Acireductone Dioxygenase 1 (ADI1) as Potential Therapeutic Targets in Poor Prognosis Endometrial Cancer.

    Cancers 14 -. .

    [doi:10.3390/cancers14122842]

  • Sanchez, E; Santos, MD; Nuñez-Garcia M; Bueno, M; Sajoux, I; Yeramian, A; Lecube, A

    Randomized Clinical Trial to Evaluate the Morphological Changes in the Adventitial Vasa Vasorum Density and Biological Markers of Endothelial Dysfunction in Subjects with Moderate Obesity Undergoing a Very Low-Calorie Ketogenic Diet.

    Nutrients 14 -. .

    [doi:10.3390/nu14010033]

  • Sanchez, E; Lecube, A; Betriu À; Hernandez, C; Lopez-Cano, C; Gutierrez-Carrasquilla, L; Kerkeni, M; Yeramian, A; Purroy, F; Pamplona, R; Farràs C; Fernandez, E; Barbe, F; Simo, R; ILERVAS project; Hernández M; Rius F; Polanco D; de la Torre MS; Torres G; Godoy P; Portero-Otin M; Jové M; Colàs-Compàs L; Benabdelhak I; Miquel E; Ortega M; Valdivielso JM; Bermúdez M; Martínez-Alonso M

    Subcutaneous advanced glycation end-products and lung function according to glucose abnormalities: The MR-1 ILERVAS Project

    Diabetes & metabolism 45 595-598. .

    [doi:10.1016/j.diabet.2018.04.002]

  • Lopez-Cano, C; Gutierrez-Carrasquilla, L; Sanchez, E; Gonzalez, J; Yeramian, A; Marti, R; Hernandez, M; Cao, G; Ribelles, M; Gomez, X; Barril, S; Barbe, F; Hernandez, C; Simo, R; Lecube, A

    Sympathetic Hyperactivity and Sleep Disorders in Individuals With Type 2 Diabetes

    Frontiers in Endocrinology 10 752-752. .

    [doi:10.3389/fendo.2019.00752]

  • Sanchez, E; Betriu, A; Yeramian, A; Fernandez, E; Purroy, F; Sanchez-de-la-Torre, M; Pamplona, R; Miquel, E; Kerkeni, M; Hernandez, C; Simo, R; Lecube, A; Hernandez, M; Rius, F; Polanco, D; Barbe, F; Torres, G; Suarez, G; Portero-Otin, M; Jove, M; Colas-Campas, L; Benabdelhak, I; Farras, C; Ortega, M; Valdivielso, JM; Bermudez-Lopez, M; Martinez-Alonso, M; ILERVAS Project

    Skin Autofluorescence Measurement n Subclinical Atheromatous Disease: Results from the ILERVAS Project

    Journal of Atherosclerosis and Thrombosis 26 879-889. .

    [doi:10.5551/jat.47498]

  • Lopez-Cano, C; Rius, F; Sanchez, E; Gaeta, AM; Betriu À; Fernandez, E; Yeramian, A; Hernandez, M; Bueno, M; Gutierrez-Carrasquilla, L; Dalmases, M; Lecube, A

    The influence of sleep apnea syndrome and intermittent hypoxia in carotid adventitial vasa vasorum

    PLOS ONE 14 -. .

    [doi:10.1371/journal.pone.0211742]

Projects

  • ¿CONOCER LA PREDISPOSICION GENETICA DEL PACIENTE CON OBESIDAD AYUDA A MEJORAR LA EFICACIA DE LA CIRUGÍA BARIÁTRICA?
  • Personalized Immunotherapy for Endometrial Cancer; Acronym: ExCITE (Endometrial Cancer Immunotherapy)
  • La serine/threonine protein kinase PRK1 en l'adipòcit de pacients amb diabetes (Ajut per a la recerca de la Societat Catalana d'Endocrinologia i Nutrició)
  • Incorporación de nuevas areas temáticas y nuevos grupos al consorcio CIBER
  • CONTRACTES D'INCORPORACIO DE CIENTIFICS I TECNOLEGS: INCORPORACIO D'UN DOCTOR PER LA REALITZACIO DE L'ESTUDI DE LA FUNCIO PULMONAR I LA RESPIRACIO DURANT LA NIT: DUES NOVES PREOCUPACIONS PER LA DIABETIS MELLITUS TIPUS 2.
  • ESTUDIO DE LA HETEROGENEIDAD TUMORAL EN EL MELANOMA
  • DISCOVERY, VALIDATION AND IMPLEMENTATION OF BIOMARKERS FOR PRECISION ONCOLOGY
  • Genomic approach for individualizing endometrial cancer diagnosis, prognosis and treatment
  • Estudio metabolómico del carcinoma de endometrio en relación a parametros morfológicos y moleculares
  • EXPRESION DE CANALES DE CALCIO DE TIPO T EN NEOPLASIAS MELANOCÍTICAS BENIGNAS Y MALIGNAS. EVALUACION DE SU APLICICABILIDAD CLINICA COMO DIANAS TERAPEUTICAS EN EL MELANOMA
  • Alteraciones moleculares relacionados con la progresión tumoral en el cáncer de endometrio
  • MECANISMOS DE REGULACION FLIP Y LA RESPUESTA A TRAIL EN EL DESARROLLO Y PROGRESION DEL CANCER